A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga- DOTANOC and 18F-FDG PET/CT

Clinical Nuclear Medicine

Volumn 38, Issue 7, 2013, Pages

  Treglia, Giorgio ^a   Salomone, Enrica ^a   Petrone, Gianluigi ^a   Giaccari, Andrea ^a   Rindi, Guido ^a   Rufini, Vittoria ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

18F FDG; 68Ga DOTANOC; Ectopic ACTH syndrome; Neuroendocrine tumors; Pancreatic tumors; PET CT

Indexed keywords

CONTRAST MEDIUM; CORTICOTROPIN; FLUORODEOXYGLUCOSE F 18; GALLIUM DOTANOC GA 68; HYDROCORTISONE; UNCLASSIFIED DRUG;

ADULT; AMENORRHEA; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORTICOTROPIN RELEASE; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DRUG UPTAKE; ECTOPIC CORTICOTROPIN PRODUCTION; FACE EDEMA; FEMALE; HIRSUTISM; HUMAN; HUMAN TISSUE; LEG EDEMA; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATIC NEUROENDOCRINE TUMOR; RARE DISEASE;

ACTH SYNDROME, ECTOPIC; ADULT; CELL DIFFERENTIATION; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MULTIMODAL IMAGING; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; ORGANOMETALLIC COMPOUNDS; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880388356     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318279ec68     Document Type: Article

References (14)

1. Alexandraki KI, Grossman AB. The ectopic ACTH syndrome. Rev Endocr Metab Disord. 2010;11:117-126.
2. Duarte PS, Zhuang H, Gusmao Mde L, et al. In-111 octreotide uptake in the thymus in a patient with Cushing's syndrome. Clin Nucl Med. 2002;27:453-454.
3. Corsello SM, Fintini D, Lovicu RM, et al. Ectopic ACTH syndrome due to occult bronchial carcinoid. Clin Nucl Med. 2009;34:459-461.
4. Zemskova MS, Gundabolu B, Sinaii N, et al. Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropinsecreting tumors. J Clin Endocrinol Metab. 2010;95:1207-1219.
5. Doi M, Sugiyama T, Izumiyama H, et al. Clinical features and management of ectopic ACTH syndrome at a single institute in Japan. Endocr J. 2010;57: 1061-1069.
6. Xu H, Zhang M, Zhai G, et al. The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumors. Endocrine. 2009;36:385-391.
7. Moraes AB, Taboada GF, Carneiro MP, et al. Utility of [(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in the localization of ectopic ACTHsecreting tumors. Pituitary. 2009;12:380-383.
8. Kumar J, Spring M, Carroll PV, et al. 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours. Clin Endocrinol. 2006;64:371-374.
9. Pacak K, Ilias I, Chen CC, et al. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-DPhe- pentetreotide scintigraphy in the localization of ectopic adrenocorticotropinsecreting tumors causing Cushing's syndrome. J Clin Endocrinol Metab. 2004; 89:2214-2221.
10. Jackson TA, Choong KW, Eng JA, et al. F-18 FDG PET/CT imaging of endogenous Cushing syndrome. Clin Nucl Med. 2011;36:e231Ye232.
11. Wu H, Wang C, Liu S, et al. Adrenocorticotropic hormone-secreting tumor in the pancreas identified by PET/CT. Clin Nucl Med. 2012;37:296-297.
12. Treglia G, Castaldi P, Rindi G, et al. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: A meta-analysis. Endocrine. 2012; 42:80-87.
13. Rufini V, Baum RP, Castaldi P, et al. Role of PET/CT in the functional imaging of endocrine pancreatic tumors. Abdom Imaging. 2012. DOI: 10.1007/s00261-012-9871-9.
14. Ambrosini V, Campana D, Tomassetti P, et al. (68)Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. Eur J Nucl Med Mol Imaging. 2012; 39(suppl 1):52-60.